How does COVID-19 affect prostate cancer?

Published Date: 14 Mar 2023

As the COVID-19 pandemic spreads, access to and delivery of health services has been disrupted like never before. How has it affected the treatment of prostate cancer?

Read Full News

Latest News

HLTH Europe 2026

Read clinically focused news coverage of key developments from HLTH Europe 2026

Data Updates Shift Treatment Standards in Gyn-Oncology

At ASCO 2026, Dr Susana Campos reviews pivotal gyn-onc updates, from practice-changing long-term IO survival in endometrial cancer to next-generation ADCs.

UC Care Shifts: What’s Changed in the New ACG Guideline?

In this interview, Dr David Rubin discusses the changes in ulcerative colitis care that led to the ACG clinical guideline update.

Highlights in Prostate Cancer From AUA 2026

Extent of lymph node dissection, defining high-risk criteria, oral androgen deprivation therapy (ADT), and darolutamide plus ADT are among the highlights for prostate cancer management from AUA 2026.

Frozen Testicular Tissue Yields Sperm After 15 Years

A Belgian team has reported sperm production after transplanting testicular tissue frozen for more than 15 years, a potential breakthrough for fertility preservation in boys.

One Doctor’s Mission to Spread AI Literacy in Medicine

A medical oncologist seeks to use his computer science knowledge to make AI understandable to the medical community.

Todays Updates

Committee Recommends Canada Not Permit Euthanasia Solely for Mental Illness

Euthanasia should not be allowed for people seeking to be killed by medical professionals exclusively for mental illness reasons, according to a report published on...

New Immune Therapy Boosts Disease Control in Prostate Cancer

An adenoviral-based immunotherapy improved disease-free survival in men with localized intermediate- or high-risk disease, but experts had reservations.

Todays Updates

Committee Recommends Canada Not Permit Euthanasia Solely for Mental Illness

Euthanasia should not be allowed for people seeking to be killed by medical professionals exclusively for mental illness reasons, according to a report published on...

New Immune Therapy Boosts Disease Control in Prostate Cancer

An adenoviral-based immunotherapy improved disease-free survival in men with localized intermediate- or high-risk disease, but experts had reservations.

Latest News

Read clinically focused news coverage of key developments from HLTH Europe 2026

At ASCO 2026, Dr Susana Campos reviews pivotal gyn-onc updates, from practice-changing long-term IO survival in endometrial cancer to next-generation ADCs.

In this interview, Dr David Rubin discusses the changes in ulcerative colitis care that led to the ACG clinical guideline update.

Extent of lymph node dissection, defining high-risk criteria, oral androgen deprivation therapy (ADT), and darolutamide plus ADT are among the highlights for prostate cancer management from AUA 2026.

A Belgian team has reported sperm production after transplanting testicular tissue frozen for more than 15 years, a potential breakthrough for fertility preservation in boys.

A medical oncologist seeks to use his computer science knowledge to make AI understandable to the medical community.

News All Time

Optimizing UC Therapy in the Presence of Comorbidities

Dr Corey Siegel discusses the importance of individualized therapy selection for ulcerative colitis in the presence of comorbidities.

ESMO Update: New Guidance for Rare Uveal Melanoma

Dr Teresa Amaral breaks down the essential new guidelines for uveal melanoma. Stay ahead of the latest standards in patient care.

A New Ultrapotent Opioid Emerges: What Is Cychlorphine?

Dr Robert Glatter speaks with toxicologist Dr Lewis Nelson about cychlorphine, a newly emerging synthetic opioid linked to fatal overdoses, and what clinicians should understand about detection, naloxone response, and the evolving drug landscape.

Soccer ‘Headers’ Acutely Raise Brain Damage Biomarkers

Study findings are concerning, but will the world’s most popular sport ban the practice of heading the ball?

Lipid Guidelines: Four Major Concerns

Too many Class I recommendations lacking supporting data from randomized trials and intellectual conflicts of interest are among John Mandrola’s complaints about the ACC/AHA guidelines on dyslipidemia.

Canadian EHR Interoperability Weak, Uneven, Harming Patients

Most Canadian physicians use electronic health records, but a lack of connectivity means that patient health information remains siloed across different software programs.

Angiolipoleiomyoma Masquerading as Leiomyoma in a Woman

A 45-year-old woman with a 2-year vaginal foreign body sensation and constipation has a large posterior vaginal wall mass; a biopsy suggests leiomyoma, but excision reveals angiolipoleiomyoma.

Adding Lanes to the Healthcare Highway

Patients can now call, message, upload photos, complete e-visits, see primary care, go to urgent care, or request specialty care directly. And yet the backlog keeps growing. So does the inbox.

Beyond CAR-T: The Rising Potential of Natural Killer Cells

Prof David Kerr explores gene-edited NK cells and allogeneic banks as a potent, ‘off-the-shelf’ alternative to autologous CAR-T infusions.

‘Too Good to Be True?’ GLP-1s and Breast Cancer Survival

Dr F. Perry Wilson breaks down study findings suggesting a link between GLP-1 drugs and improved outcomes among patients with breast cancer and obesity.

Upper GI Disorders: New Evidence May Refine Practice

Dr David Johnson summarizes pivotal DDW 2026 studies, spotlighting emerging evidence across upper GI disorders — from Barrett’s esophagus surveillance to pancreatitis management.

Testosterone Is Back; Have We Learned From Our Mistakes?

A new push to prescribe testosterone replacement therapy led this cardiologist to review the cardiovascular risk data.

The Pitt Season 2: EM Docs Tackle Tough Diagnoses (Part 3)

Drs Robert Glatter and Amy Faith Ho continue their review of The Pitt season 2, tackling retinal artery occlusion, phytophotodermatitis, and ovarian torsion. They unpack clinical accuracy, informed consent, and bias in emergency care.

Conference MDAngle: AUA 2026 Metastatic Prostate Cancer

Insights from AUA 2026, including anticipated presentations, key takeaways, and how new research in metastatic prostate cancer will affect patient care.

AUA 2026: Previewing Metastatic Prostate Cancer Updates

Dr Hannah McManus looks ahead to the release of new data from phase 3 clinical trials that will inform multidisciplinary management.

Updates in Ovarian Cancer From SGO 2026

Landmark survival gains in ROSELLA and KEYNOTE-B96 in platinum-resistant disease plus pivotal data in low-grade serous ovarian cancer are highlights from SGO 2026, reported by Dr Amelia Jernigan.

Recommended News For You

Coffee, Tea Tied to Lower Risk of Head and Neck Cancer

Could the Prostate Cancer Story of Francis Collins Dissuade Men from Active Surveillance?

New imaging probe helps track prostate cancer and possibly treat it before resistance develops

Obesity-related cancer rising among both younger and older adults worldwide, study finds

Radioligand Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer

Can patients receiving immunotherapy for cancer benefit from taking vitamin D supplements?

Research identifies nearly 200 potential breast carcinogens in food packaging materials

Recommended Articles For You

The Importance of Balanced Potassium Levels in Maintaining Good Health 

Respiratory Ramifications of Systemic Disease: A Comprehensive Review 

Mastering Breast Cancer Care in 2025: Diagnosis, Treatment, Education, and Innovation 

Mechanisms, Efficacy, and Survival Outcomes in AML, Squamous Cell Carcinoma, & Non-Hodgkin Lymphoma 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.

2.

iPSC-based vaccines: A new hope for preventing and treating colorectal cancer

3.

Child Death Rates Are Rising in the U. s. ; Water Beads Warning; Cancer Studies Retracted.

4.

FDA Expands Use of T-DXd in Early HER2+ Breast Cancer

5.

Additional imaging techniques can detect early stage cancers missed by mammograms in women with dense breasts

1.

The Basics of M.C.V Normal Range for Better Health Management

2.

Diagnosis and Treatment of Follicular Thyroid Cancer: A Comprehensive Guide

3.

Using Node Technology to Fight Breast Cancer: A New Hope for Early Detection

4.

Unlocking the Potential of Leukemia Treatment: A New Hope for Patients

5.

Evidence-Based Advances in Hematology for Specialists

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months

2.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V

3.

Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients

4.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II

5.

Current Scenario of Cancer- Q&A Session to Close the Gap

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot